The Boundary Impact Ventures thesis
in 140 characters:
Invest in high-impact, translational scientific research projects "too late" for grants, but "too early" for traditional venture capital.
What is impact investing for science?
The science funding ecosystem, historically serviced by a bifurcated capital mix of grants and investments, has many elements that make it a natural fit for applying impact investing principles. This post describes our thesis and approach for bringing impact investments to science.
Drawing from principles of conventional philanthropy, venture capital and private equity, our goal is to unlock value from meaningful scientific innovations that otherwise would not be funded under traditional market structures.
We approach science as an alternative asset class, with risk-return characteristics that are attractive to deep value-oriented investors.
Interested in science as an alternative asset?
Sign up for our periodic proprietary research reports and join our investor working group discussing how to incorporate a science-thesis into the portfolio mix.
We field a diverse, cross-sector team
Andrew Wong (@akwwong)
Combining his experience as a funder of basic research and years working across the global financial system, Andrew started Boundary Impact Ventures to advance scientific breakthroughs.
Pilot fund advisors
Sam Arbesman, Shawn Carbonell, Alison Urkowitz Green, Wilson Lin, Yale Mao, Michael Winer, Nicholas Yiu